Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

FDA merges all adverse event reporting systems into new AEMS platform
Adverse event reports for food, drugs, vaccines, dietary supplements and medical devices will soon be available in one place. The U.S. Food and Drug Administration said the change will simplify reporting for consumers and allow it to react in real-time to FOIA requests.
Medical device manufacturer hit by cyberattack, possibly from Iranian-backed hackers
Stryker, a Michigan-based company that manufactures surgical implants, confirmed it was experiencing a global network outage. Employee devices reportedly displayed the logo of a pro-Iran cybercrime cell.
Medicare Advantage fraud allegations against Aetna settled for nearly $118M
The U.S. Department of Justice said the insurer upcoded patient diagnoses to boost risk-adjusted payments it received from the Centers for Medicare & Medicaid Services. The company did not admit to wrongdoing, despite agreeing to the payout.
FTC seeks more time to settle insulin pricing lawsuit with remaining PBM defendants
The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own.
Blood filtration company fined $5.7M, executive charged, for covering up patient deaths
The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.

Ascension Health in 'advanced talks' to buy Amsurg from private equity for $3.9B

The acquisition would allow Ascension—a nonprofit health system—to expand its outpatient surgery network, as Amsurg operates 250 centers nationwide. Sources said a final deal could be mere weeks away.

Number of physicians working for small practices drops below 50% for the first time, AMA says

A new report from the American Medical Association reveals that doctors are increasingly likely to work for larger provider groups and hospitals, as single specialty practices slowly disappear.

Cigna, CVS sue to block Arkansas' PBM regulation

The newly signed law, known as Act 264, bans pharmacy benefit managers from owning pharmacies in the state. It's scheduled to go into effect beginning in 2026.

Healthcare AI newswatch: MAHA’s AI stumble, OpenAI’s healthcare offensive, Mayo’s AI startup support, more

Mayo Clinic is looking to give promising medtech startups a seriously running start. Toward that end, the august institution has launched the new Mayo Venture Partner program.

Walmart launches AI tool to steer Medicare Advantage members toward ‘healthy’ foods

Walmart is highlighting food and products eligible for purchase using Medicare Advantage supplemental funds through its app, while also using AI to algorithmically help enrollees build diet-appropriate shopping lists.

Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and an associate professor of health policy and management, Harvard School of Public Health, explains the impact of private equity ownership of hospitals and private practices.

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.

Q&A: Universities, tech collaborate to predict opioid overdose with wearables

The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative.

openAI united arab emirates UAE artificial intelligence

AI newswatch: OpenAI goes to the UAE, patients get cyberchondria, more

Like remoras hitching a ride on a shark, private businesses are capitalizing on President Trump’s AI-aggressive trip to the Middle East.

Business Intelligence

FDA merges all adverse event reporting systems into new AEMS platform

Medical device manufacturer hit by cyberattack, possibly from Iranian-backed hackers

Medicare Advantage fraud allegations against Aetna settled for nearly $118M

FTC seeks more time to settle insulin pricing lawsuit with remaining PBM defendants

Blood filtration company fined $5.7M, executive charged, for covering up patient deaths